Thrivent Financial for Lutherans’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.84M | Buy |
26,076
+3,668
| +16% | +$914K | 0.01% | 834 |
|
|
2025
Q4 | $5.43M | Buy |
22,408
+11,481
| +105% | +$2.94M | 0.01% | 912 |
|
|
2025
Q3 | $2.99M | Sell |
10,927
-1,172
| -10% | -$320K | 0.01% | 1094 |
|
|
2025
Q2 | $3.11M | Buy |
12,099
+5,212
| +76% | +$1.24M | 0.01% | 1065 |
|
|
2025
Q1 | $1.56M | Buy |
6,887
+1
| +0% | +$233 | ﹤0.01% | 1426 |
|
|
2024
Q4 | $1.59M | Sell |
6,886
-66
| -0.9% | -$15.9K | ﹤0.01% | 1602 |
|
|
2024
Q3 | $1.7M | Buy |
6,952
+755
| +12% | +$169K | ﹤0.01% | 1558 |
|
|
2024
Q2 | $1.19M | Sell |
6,197
-71
| -1% | -$14.4K | ﹤0.01% | 1775 |
|
|
2024
Q1 | $1.24M | Sell |
6,268
-118
| -2% | -$21.6K | ﹤0.01% | 1766 |
|
|
2023
Q4 | $1.1M | Sell |
6,386
-11,782
| -65% | -$1.81M | ﹤0.01% | 1785 |
|
|
2023
Q3 | $2.69M | Sell |
18,168
-12,603
| -41% | -$2.28M | 0.01% | 1100 |
|
|
2023
Q2 | $6.72M | Buy |
30,771
+22,638
| +278% | +$5.05M | 0.02% | 751 |
|
|
2023
Q1 | $1.78M | Sell |
8,133
-1,005
| -11% | -$218K | ﹤0.01% | 1377 |
|
|
2022
Q4 | $1.9M | Buy |
9,138
+142
| +2% | +$31.2K | ﹤0.01% | 1292 |
|
|
2022
Q3 | $1.96M | Sell |
8,996
-411
| -4% | -$93.5K | 0.01% | 1231 |
|
|
2022
Q2 | $1.97M | Sell |
9,407
-155
| -2% | -$33K | 0.01% | 1237 |
|
|
2022
Q1 | $2.32M | Buy |
9,562
+661
| +7% | +$160K | ﹤0.01% | 1231 |
|
|
2021
Q4 | $2.28M | Sell |
8,901
-562
| -6% | -$146K | ﹤0.01% | 1297 |
|
|
2021
Q3 | $2.49M | Buy |
9,463
+580
| +7% | +$159K | 0.01% | 1209 |
|
|
2021
Q2 | $2.19M | Buy |
8,883
+1,097
| +14% | +$231K | ﹤0.01% | 1366 |
|
|
2021
Q1 | $1.51M | Sell |
7,786
-107
| -1% | -$21.5K | ﹤0.01% | 1591 |
|
|
2020
Q4 | $1.68M | Buy |
7,893
+1,314
| +20% | +$262K | ﹤0.01% | 1422 |
|
|
2020
Q3 | $1.13M | Sell |
6,579
-112
| -2% | -$20.7K | ﹤0.01% | 1497 |
|
|
2020
Q2 | $1.28M | Sell |
6,691
-87,396
| -93% | -$14.3M | ﹤0.01% | 1335 |
|
|
2020
Q1 | $13.9M | Buy |
94,087
+366
| +0.4% | +$58.3K | 0.05% | 405 |
|
|
2019
Q4 | $14.5M | Buy |
93,721
+9,618
| +11% | +$1.39M | 0.04% | 465 |
|
|
2019
Q3 | $11.4M | Buy |
84,103
+1,756
| +2% | +$230K | 0.04% | 476 |
|
|
2019
Q2 | $10M | Buy |
82,347
+59
| +0.1% | +$6.54K | 0.03% | 515 |
|
|
2019
Q1 | $8.56M | Buy |
82,288
+76,049
| +1,219% | +$7.85M | 0.03% | 529 |
|
|
2018
Q4 | $710K | Buy |
6,239
+110
| +2% | +$11.8K | ﹤0.01% | 1370 |
|
|
2018
Q3 | $707K | Buy |
6,129
+135
| +2% | +$14.8K | ﹤0.01% | 1492 |
|
|
2018
Q2 | $621K | Buy |
5,994
+72
| +1% | +$7.29K | ﹤0.01% | 1560 |
|
|
2018
Q1 | $583K | Buy |
5,922
+174
| +3% | +$16.4K | ﹤0.01% | 1561 |
|
|
2017
Q4 | $487K | Buy |
5,748
+118
| +2% | +$9.75K | ﹤0.01% | 1707 |
|
|
2017
Q3 | $433K | Sell |
5,630
-22,840
| -80% | -$1.75M | ﹤0.01% | 1645 |
|
|
2017
Q2 | $2.22M | Buy |
28,470
+1,820
| +7% | +$130K | 0.01% | 790 |
|
|
2017
Q1 | $1.92M | Buy |
26,650
+2,610
| +11% | +$180K | 0.01% | 861 |
|
|
2016
Q4 | $1.49M | Sell |
24,040
-22,300
| -48% | -$1.37M | 0.01% | 972 |
|
|
2016
Q3 | $3M | Buy |
46,340
+26,490
| +133% | +$1.76M | 0.01% | 751 |
|
|
2016
Q2 | $1.25M | Buy |
19,850
+1,850
| +10% | +$109K | 0.01% | 1018 |
|
|
2016
Q1 | $1.04M | Buy |
18,000
+1,880
| +12% | +$106K | 0.01% | 1063 |
|
|
2015
Q4 | $865K | Buy |
16,120
+470
| +3% | +$26.5K | ﹤0.01% | 1116 |
|
|
2015
Q3 | $798K | Buy |
15,650
+1,300
| +9% | +$70K | ﹤0.01% | 1029 |
|
|
2015
Q2 | $809K | Buy |
14,350
+3,200
| +29% | +$202K | ﹤0.01% | 901 |
|
|
2015
Q1 | $800K | Buy |
11,150
+200
| +2% | +$13K | ﹤0.01% | 918 |
|
|
2014
Q4 | $614K | Hold |
10,950
| – | – | ﹤0.01% | 1016 |
|
|
2014
Q3 | $540K | Buy |
10,950
+150
| +1% | +$7.64K | ﹤0.01% | 1072 |
|
|
2014
Q2 | $547K | Sell |
10,800
-200
| -2% | -$9.91K | ﹤0.01% | 1084 |
|
|
2014
Q1 | $492K | Sell |
11,000
-28,000
| -72% | -$1.26M | ﹤0.01% | 967 |
|
|
2013
Q4 | $1.84M | Sell |
39,000
-632,200
| -94% | -$32M | 0.01% | 626 |
|
|
2013
Q3 | $35.5M | Buy |
671,200
+7,800
| +1% | +$378K | 0.22% | 99 |
|
|
2013
Q2 | $29.9K | Buy |
+663,400
| New | +$31.5M | 0.19% | 120 |
|
Other funds holding RMD
VCM
VPM
DAM
Thrivent Financial for Lutherans's RMD Position: Q1 2026 in Review
Thrivent Financial for Lutherans increased its ResMed (RMD) stake by 16% in Q1 2026, buying an estimated $914K and bringing the position to 26,076 shares worth $5.84M. The position accounts for 0.01% of the portfolio, ranked #834.
Thrivent Financial for Lutherans first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $35.5M in Q3 2013. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Thrivent Financial for Lutherans held 26,076 shares of ResMed worth $5.84M as of Q1 2026.
- Thrivent Financial for Lutherans bought 3,668 ResMed shares in Q1 2026, an estimated $914K.
- ResMed made up 0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #834 holding.
- Thrivent Financial for Lutherans first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
- Thrivent Financial for Lutherans's ResMed position peaked at $35.5M in Q3 2013.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.